Zurich Cantonal Bank
COGT icon

Zurich Cantonal Bank’s Cogent Biosciences COGT Stock Holding History

Zurich Cantonal Bank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
52,702
+29,845
+131% +$1.04M ﹤0.01% 1126
2026
Q1 		$880K Buy
22,857
+419
+2% +$15.5K ﹤0.01% 1506
2025
Q4 		$797K Sell
22,438
-22,281
-50% -$626K ﹤0.01% 1485
2025
Q3 		$642K Buy
44,719
+23,801
+114% +$282K ﹤0.01% 1588
2025
Q2 		$150K Buy
20,918
+13,894
+198% +$77K ﹤0.01% 2254
2025
Q1 		$42.1K Hold
7,024
– – ﹤0.01% 2530
2024
Q4 		$54.8K Sell
7,024
-11,910
-63% -$119K ﹤0.01% 2546
2024
Q3 		$204K Hold
18,934
– – ﹤0.01% 2095
2024
Q2 		$160K Hold
18,934
– – ﹤0.01% 2149
2024
Q1 		$127K Hold
18,934
– – ﹤0.01% 2277
2023
Q4 		$111K Buy
18,934
+7,606
+67% +$58.3K ﹤0.01% 2396
2023
Q3 		$110K Buy
11,328
+2,571
+29% +$30.5K ﹤0.01% 2311
2023
Q2 		$104K Hold
8,757
– – ﹤0.01% 2337
2023
Q1 		$94.5K Sell
8,757
-2,776
-24% -$35.5K ﹤0.01% 2312
2022
Q4 		$133K Buy
11,533
+8,225
+249% +$102K ﹤0.01% 2085
2022
Q3 		$49K Hold
3,308
– – ﹤0.01% 2595
2022
Q2 		$30K Sell
3,308
-304
-8% -$2.08K ﹤0.01% 2721
2022
Q1 		$27K Buy
+3,612
New +$25.2K ﹤0.01% 2631

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Zurich Cantonal Bank's COGT Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Cogent Biosciences (COGT) stake by 131% in Q2 2026, buying an estimated $1.04M and bringing the position to 52,702 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Zurich Cantonal Bank first reported a position in COGT in Q1 2022 and has held it in 18 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Zurich Cantonal Bank held 52,702 shares of Cogent Biosciences worth $2.04M as of Q2 2026.
  • Zurich Cantonal Bank bought 29,845 Cogent Biosciences shares in Q2 2026, an estimated $1.04M.
  • Cogent Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1126 holding.
  • Zurich Cantonal Bank first reported a position in Cogent Biosciences in Q1 2022 and has held it in 18 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.